Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis

References

• Yin H, Lim CC, Ma L, Gao Y, Cai Y, Li D, et al. Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis. J Neurol. 2004; 251: 1249–54
   PubMed Web of Science ®Google Scholar
• Wang S, Poptani H, Woo JH, Desiderio LM, Elman LB, McCluskey LF, et al. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology. 2006; 239: 831–8
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Ulug AM, Pullman SL, Gooch CL, Chan S, Tang MX, et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology. 2007; 68: 1402–10
   PubMed Web of Science ®Google Scholar
• Ellis CM, Simmons A, Jones DK, Bland J, Dawson JM, Horsfield MA, et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology. 1999; 53: 1051–8
   PubMed Web of Science ®Google Scholar
• Karlsborg M, Rosenbaum S, Wiegell M, Simonsen H, Larsson H, Werdelin L, et al. Corticospinal tract degeneration and possible pathogenesis in ALS evaluated by MR diffusion tensor imaging. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 136–40
   PubMed Web of Science ®Google Scholar
• Hong YH, Lee KW, Sung JJ, Chang KH, Song IC. Diffusion tensor MRI as a diagnostic tool of upper motor neuron involvement in amyotrophic lateral sclerosis. J Neurol Sci. 2004; 227: 73–8
   PubMed Web of Science ®Google Scholar
• Wong JC, Concha L, Beaulieu C, Johnston W, Allen PS, Kalra S. Spatial profiling of the corticospinal tract in amyotrophic lateral sclerosis using diffusion tensor imaging. J Neuroimaging. 2007; 17: 234–40
   PubMed Web of Science ®Google Scholar
• Iwata NK, Aoki S, Okabe S, Arai N, Terao Y, Kwak S, et al. Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation. Neurology. 2008; 70: 528–32
   PubMed Web of Science ®Google Scholar
• Thivard L, Pradat PF, Lehericy S, Lacomblez L, Dormont D, Chiras J, et al. Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability. J Neurol Neurosurg Psychiatry. 2007; 78: 889–92
   PubMed Web of Science ®Google Scholar
• Ciccarelli, O, Behrens, TE, Johansen-Berg, H, Talbot, K, Orrell, RW, Howard, RS, , et al. Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics. Hum Brain Mapp. 2008.
   Web of Science ®Google Scholar
• Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology. 1994; 44: 1933–8
   PubMed Web of Science ®Google Scholar
• Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin L. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology. 1997; 48: 878–81
   PubMed Web of Science ®Google Scholar
• Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, Weiner MW. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology. 1998; 50: 1800–5
   PubMed Web of Science ®Google Scholar
• Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport. 1998; 9: 1757–61
   PubMed Web of Science ®Google Scholar
• Block W, Karitzky J, Traber F, Pohl C, Keller E, Mundegar RR, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol. 1998; 55: 931–6
   PubMedGoogle Scholar
• Schuff N, Rooney WD, Miller R, Gelinas DF, Amend DL, Maudsley AA, et al. Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis. Magn Reson Med. 2001; 45: 513–6
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Pelliccioli GP, Tarducci R, Chiarini P, Presciutti O, Gobbi G, et al. Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology. 2001; 43: 189–97
   PubMed Web of Science ®Google Scholar
• Abe K, Takanashi M, Watanabe Y, Tanaka H, Fujita N, Hirabuki N, et al. Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology. 2001; 43: 537–41
   PubMed Web of Science ®Google Scholar
• Suhy J, Miller RG, Rule R, Schuff N, Licht J, Dronsky V, et al. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology. 2002; 58: 773–9
   PubMed Web of Science ®Google Scholar
• Rule RR, Suhy J, Schuff N, Gelinas DF, Miller RG, Weiner MW. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004; 5: 141–9
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Pullman SL, Shungu DC, Chan S, Hays AP, Del Bene ML, et al. Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology. 2004; 62: 1753–7
   PubMed Web of Science ®Google Scholar
• Kalra S, Hanstock CC, Martin WR, Allen PS, Johnston WS. Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Arch Neurol. 2006; 63: 1144–8
   PubMedGoogle Scholar
• Kalra S, Vitale A, Cashman NR, Genge A, Arnold DL. Cerebral degeneration predicts survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2006; 77: 1253–5
   PubMed Web of Science ®Google Scholar
• Kalra S, Tai P, Genge A, Arnold DL. Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging. J Neurol. 2006; 253: 1060–3
   PubMed Web of Science ®Google Scholar
• Cwik VA, Hanstock CC, Allen PS, Martin WR. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology. 1998; 50: 72–7
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293–9
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N. Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicentre clinical trials. J Neurol Sci. 1997; 152(1)S1–9
   PubMed Web of Science ®Google Scholar
• Kent-Braun JA, Walker CH, Weiner MW, Miller RG. Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle & Nerve. 1998; 21: 762–8
   PubMed Web of Science ®Google Scholar
• Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002; 17: 143–55
   PubMed Web of Science ®Google Scholar
• Rademacher J, Burgel U, Geyer S, Schormann T, Schleicher A, Freund HJ, et al. Variability and asymmetry in the human precentral motor system. A cytoarchitectonic and myeloarchitectonic brain mapping study. Brain. 2001; 124: 2232–58
   PubMed Web of Science ®Google Scholar
• Mori S, van Zijl PC. Fibre tracking: principles and strategies – a technical review. NMR Biomed. 2002; 15: 468–80
   PubMed Web of Science ®Google Scholar
• Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SC, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology. 1998; 51: 1104–9
   PubMed Web of Science ®Google Scholar
• Maekawa S, al Sarraj S, Kibble M, Landau S, Parnavelas J, Cotter D, et al. Cortical selective vulnerability in motor neuron disease: a morphometric study. Brain. 2004; 127: 1237–51
   PubMed Web of Science ®Google Scholar
• Ziemann U, Winter M, Reimers CD, Reimers K, Tergau F, Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation. Neurology. 1997; 49: 1292–8
   PubMed Web of Science ®Google Scholar
• Lloyd CM, Richardson MP, Brooks DJ, Al Chalabi A, Leigh PN. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain. 2000; 123: 2289–96
   PubMed Web of Science ®Google Scholar
• Parent A. Carpenter's Human Neuroanatomy9th edn. Williams and Wilkins, Baltimore 1996
   Google Scholar
• Martin JE, Swash M. The pathology of motor neuron disease. Motor Neuron Disease. Biology and Management, PN Leigh, M Swash. Springer-Verlag, London 1995; 93–118
   Google Scholar
• Abe O, Yamada H, Masutani Y, Aoki S, Kunimatsu A, Yamasue H, et al. Amyotrophic lateral sclerosis: diffusion tensor tractography and voxel-based analysis. NMR Biomed. 2004; 17: 411–6
   PubMed Web of Science ®Google Scholar
• Sach M, Winkler G, Glauche V, Liepert J, Heimbach B, Koch MA, et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain. 2004; 127: 340–50
   PubMed Web of Science ®Google Scholar
• Sage CA, Peeters RR, Gorner A, Robberecht W, Sunaert S. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage. 2007; 34: 486–99
   PubMed Web of Science ®Google Scholar
• Agosta F, Pagani E, Rocca MA, Caputo D, Perini M, Salvi F, et al. Voxel based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp. 2007; 28: 1430–8
   PubMed Web of Science ®Google Scholar
• Katz MH. Multivariable analysis: a practical guide for clinicians. Cambridge University Press, Cambridge 1999
   Google Scholar